ADMA Biologics Sees FY2026 Sales $530.000M-$560.000M vs $632.367M Est

Benzinga Newsdesk www.benzinga.com Positive 73.6%

Neg 0% Neu 0% Pos 73.6%

ADMA Biologics (NASDAQ:ADMA) sees FY2026 sales of $530.000 million-$560.000 million vs $632.367 million analyst estimate.